NEWS & MEDIA

CB Defense Today with guest Dr. Jason Roos
November 9, 2021 — CB Defense Today is a quarterly recorded interview, where CBC Director, Dr. Eric L. Moore talks with other leaders across the CB Defense Enterprise. This September Dr. Moore’s guest was Joint Program Executive Officer for CBRND, Dr. Jason Roos. The two discussed the valuable partnership between CBC and JPEO for Chemical, Biological, Radiological and Nuclear Defense, pandemic preparedness in the chemical biological defense space, and improving warfighter protection and decontamination in the field based on future operating environments... MORE

Screenshot of CB Defense Today with guest Dr. Jason Roos

Newly Confirmed Assistant Secretary of Defense, Other DOD Officials Make Inaugural Visit to JPEO-CBRND
November 5, 2021 — Ms. Deborah Rosenblum, the Assistant Secretary of Defense for Nuclear, Chemical, and Biological Defense Programs (ASD(NCB)) and several other DOD officials visited the headquarters of the Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear (CBRN) Defense (JPEO-CBRND) at the Aberdeen Proving Ground - Edgewood, Md., on Monday, October 25, 2021. This was Ms. Rosenblum’s first visit to JPEO-CBRND after her Senate confirmation vote on July 29, 2021. ... MORE

DOD Awards Dynavax $22 Million for Plague Vaccine Clinical Trial
November 3, 2021 — The U.S. Department of Defense (DOD) awarded Dynavax Technologies Corporation with an agreement worth approximately $22 million over two and a half years, to execute a clinical trial combining the DOD’s recombinant plague (rF1V) vaccine with its own CpG 1018® adjuvant. Under the agreement, Dynavax will conduct a Phase II clinical trial in 2022. ... MORE

Key Federal Partners Gather to Plan, Act on Emerging CBRN Threats
October 12, 2021 — Efforts to prepare the U.S. military for a series of evolving threats to both the Warfighter and the nation at-large took center stage during the 2021 CBRN Defense Conference and Exhibition in Baltimore, Maryland from August 16-18... MORE

CBRND leadership speak on a panel at the 2021 CBRN Defense Conference

JPM CBRN Medical Provides Relief and Recovery in the Age of a Global Pandemic
October 4, 2021 — The JPM CBRN Medical team is dedicated to mission, warfighter, and Nation. Their work has been instrumental in bringing novel testing capability to the U.S., delivering critical at-home technology necessary to combat the global COVID-19 pandemic. In spearheading the mission of supporting the warfighter, the team indirectly boosted the local economy and remain ready for the next threat, whether intentional or naturally-occurring... MORE

Two uniformed service members are in a tent. One wears PPE and a faceshield, while they use a nasal swab to collect a COVID-19 sample from the other Service member in uniform.

JPM CBRN Medical Provides Relief and Recovery in the Age of a Global Pandemic
September 8, 2021 — What do global pandemic relief efforts, the U.S. Army, and a local Maryland economy have in common? The answer is fearless innovation, the right people in the right place at the right time, and an Australian-based biotech and diagnostic solutions company named Ellume. ... MORE

Aerial photo of Ellume's new Fredrick, MD diagnostics manufacturing facility.

DOD Awards $64.6 Million Contract to SiO2 Medical Products to Increase Domestic Production Capacity of Pharmaceutical Vials
July 29, 2021 — IMMEDIATE RELEASE - On July 26, 2021, the Department of Defense (DOD), on behalf of and in coordination with the Department of Health and Human Services (HHS), awarded a $64.6 million contract modification to SiO2 Medical Products to increase domestic production of pharmaceutical vials made of hybrid, glass-equivalent materials... MORE

Crystal Tyler, pharmacy technician, prepares an injection for an Operation Warp Speed patient volunteer at Brooke Army Medical Center, Fort Sam Houston, Texas, November 16, 2020. BAMC and Wilford Hall Ambulatory Surgical Center are participating in the Phase III trial to evaluate the vaccine under development by AstraZeneca as part of a national initiative to accelerate the development, production and distribution of COVID-19 vaccines, therapeutics and diagnostics.

Biden Administration announces U.S. government procurement of Merck’s investigational antiviral medicine for COVID-19 treatment
June 9, 2021 — The Biden Administration today announced that the U.S. government will procure approximately 1.7 million courses of an investigational antiviral treatment, molnupiravir (MK-4482), for COVID-19 from Merck, pending emergency use authorization (EUA) or approval from the U.S. Food and Drug Administration (FDA).Molnupiravir (MK-4482) is designed to... MORE

American flags against a blue sky background

Memorandum of Understanding for Acquisition Support Signed Between the Department of Defense and the Department of Health and Human Services
May 26, 2021 — On May 20, 2021, Deputy Secretary of Defense Kathleen Hicks and Deputy Secretary of Health and Human Services (HHS) Andrea Palm signed a memorandum of understanding (MOU) to continue the agencies’ partnership in defeating COVID-19 and preparing for future public health emergencies.The MOU establishes the framework under which the Department of... MORE

Interview with Dr. Kevin Wingerd Chief Technology Officer at the Joint Project Manager for Chemical, Biological, Radiological, and Nuclear Medical (JPM CBRN Medical)
May 25, 2021 — Excerpt from NCT Magazine's Interview with Dr. Kevin Wingerd, Chief Technology Officer at the Joint Project Manager for Chemical, Biological, Radiological, and Nuclear Medical (JPM CBRN Medical)... MORE

News Search

News Archive - Search by Year and Month

2025 (19)
2024 (40)
2023 (36)
2022 (31)
2021 (37)
2020 (15)
2019 (11)
2018 (5)
2017 (9)
2016 (1)

CPE CBRND Press Kit

Download our press kit, which includes helpful documents to better understand our work, such as – Command Brief, Chemical Biological Defense Program's Enterprise strategy, the CPE CBRND's Capabilities Catalog, Leadership Biographies, COVID-19 fact sheets, and contracting overview documents.

CPE CBRND Public Affairs Office

The CPE CBRND Public Affairs Office coordinates and responds to all public affairs and media relations needs on behalf of the CPE CBRND. To request a speaker, subject matter expert, or for other interview or request for comment please email our Public Affairs Office email below.

The information contained in these articles has been reviewed and approved for public release.

The appearance of hyperlinks does not constitute endorsement by the JPEO-CBRND of non-U.S. government sites or the information, products, or services contained therein. Although the JPEO-CBRND may or may not use these sites as additional distribution channels for Department of Defense information, it does not exercise editorial control over all the information that you may find at these locations. Such hyperlinks are provided consistent with the stated purpose of this website.